NuGEN Technologies, Inc. Announces Addition Of Industry Veteran Dr. Michael Hunkapiller To Board Of Directors; Company Closes $7.75 Million Funding Round Led By Alloy Ventures

SAN CARLOS, Calif.--(BUSINESS WIRE)--March 21, 2006--NuGEN Technologies, Inc., a privately held company that develops and commercializes the new standard in RNA amplification and labeling systems, today announced that it has secured $7.75 million in financing and has added industry authority Dr. Michael Hunkapiller to the company's board of directors.
MORE ON THIS TOPIC